Published in Medical Letter on the CDC and FDA, July 8th, 1996
Inadequate treatment regimens and noncompliance on the part of patients are the most common reasons for the emergence of drug-resistant strains of tuberculosis.
"Scrutiny of treatment strategies has resulted in recommendations for inclusion of as many as three additional drugs to the standard three-drug regimen of isoniazid, rifampin and pyrazinamide," researcher Robert C....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.